NCT03417765 2024-10-24
Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas
VectivBio AG
Phase 1/2 Withdrawn
Clinical Trials
10 trialsNCT03955224 2021-04-08
ESMULLLAT
Institut Claudius Regaud
Phase 2 Withdrawn
NCT00728585 2018-08-07
Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant
Children's Oncology Group
Phase 2 Withdrawn
NCT01554254 2016-08-31
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation
Tarix Pharmaceuticals
Phase 2 Withdrawn
NCT01882374 2016-08-31
Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation
Tarix Pharmaceuticals
Phase 2 Withdrawn
NCT01882387 2016-08-31
Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
Tarix Pharmaceuticals
Phase 2 Withdrawn
NCT00549835 2015-04-08
Acupuncture for Mucositis Pain in Cancer Care
Johns Hopkins University
Phase NA Withdrawn
NCT01728480 2013-12-11
Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy
Roswell Park Cancer Institute
Phase 1 Withdrawn
NCT01674374 2013-05-15
Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation Therapy
Roswell Park Cancer Institute
Phase 2 Withdrawn
NCT00928161 2012-09-07
Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy
M.D. Anderson Cancer Center
Phase NA Withdrawn